These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
82 related items for PubMed ID: 6432685
21. The IgE adjuvant effect of particles: characterisation of the primary cellular response in the draining lymph node. Nygaard UC, Ormstad H, Aase A, Løvik M. Toxicology; 2005 Jan 15; 206(2):181-93. PubMed ID: 15588912 [Abstract] [Full Text] [Related]
22. Early production of IL-4 and induction of Th2 responses in the lymph node originate from an MHC class I-independent CD4+NK1.1- T cell population. von der Weid T, Beebe AM, Roopenian DC, Coffman RL. J Immunol; 1996 Nov 15; 157(10):4421-7. PubMed ID: 8906817 [Abstract] [Full Text] [Related]
23. T-cell lymphokine response to orally administered proteins during priming and unresponsiveness. Hoyne GF, Callow MG, Kuhlman J, Thomas WR. Immunology; 1993 Apr 15; 78(4):534-40. PubMed ID: 8495970 [Abstract] [Full Text] [Related]
24. Vaccination with leukemia cells expressing cell-surface-associated GM-CSF blocks leukemia induction in immunocompetent mice. Ling X, Wang Y, Dietrich MF, Andreeff M, Arlinghaus RB. Oncogene; 2006 Jul 27; 25(32):4483-90. PubMed ID: 16547503 [Abstract] [Full Text] [Related]
25. Recipient polyclonal B cell activation and immunoglobulin production induced by priming with a retroviral superantigen. Modlin CS, Muruve NA, Stanko D, Caulfield MJ, Fairchild RL. Cell Immunol; 1996 May 01; 169(2):252-63. PubMed ID: 8620553 [Abstract] [Full Text] [Related]
26. Functional heterogeneity of helper T cells: two distinct helper T cells are required for the production of T cell growth factor. Larsson EL. J Immunol; 1982 Feb 01; 128(2):742-5. PubMed ID: 6798123 [Abstract] [Full Text] [Related]
27. The ability of lymphokine and lipopolysaccharide to induce procoagulant activity in mouse macrophage cell lines. Farram E, Geczy CL, Moon DK, Hopper K. J Immunol; 1983 Jun 01; 130(6):2750-6. PubMed ID: 6602180 [Abstract] [Full Text] [Related]
28. Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes. Chin CS, Miller CH, Graham L, Parviz M, Zacur S, Patel B, Duong A, Bear HD. Int Immunol; 2004 Sep 01; 16(9):1283-94. PubMed ID: 15262898 [Abstract] [Full Text] [Related]
29. Regulation of T cell differentiation: in vitro induction of 20 alpha-hydroxysteroid dehydrogenase in splenic lymphocytes from athymic mice by a unique lymphokine. Ihle JN, Pepersack L, Rebar L. J Immunol; 1981 Jun 01; 126(6):2184-9. PubMed ID: 6971890 [Abstract] [Full Text] [Related]
30. Population dynamics of T lymphocytes. Renewal rate and expansion in the peripheral lymphoid organs. Rocha B, Freitas AA, Coutinho AA. J Immunol; 1983 Nov 01; 131(5):2158-64. PubMed ID: 6605376 [Abstract] [Full Text] [Related]
31. Comparative studies of the effects of recombinant GM-CSF and GM-CSF administered via a poxvirus to enhance the concentration of antigen- presenting cells in regional lymph nodes. Kass E, Parker J, Schlom J, Greiner JW. Cytokine; 2000 Jul 01; 12(7):960-71. PubMed ID: 10880241 [Abstract] [Full Text] [Related]
32. Alloreactive cloned T cell lines. V. Differential kinetics of IL 2, CSF, and BCSF release by a cloned T amplifier cell and its variant. Ely JM, Prystowsky MB, Eisenberg L, Quintans J, Goldwasser E, Glasebrook AL, Fitch FW. J Immunol; 1981 Dec 01; 127(6):2345-9. PubMed ID: 6975317 [Abstract] [Full Text] [Related]
33. Mast cell activation and migration to lymph nodes during induction of an immune response in mice. Wang HW, Tedla N, Lloyd AR, Wakefield D, McNeil PH. J Clin Invest; 1998 Oct 15; 102(8):1617-26. PubMed ID: 9788976 [Abstract] [Full Text] [Related]
34. Delayed hypersensitivity to Trypanosoma cruzi in mice: specific suppressor cells in chronic infection. Scott MT. Immunology; 1981 Oct 15; 44(2):409-17. PubMed ID: 6457792 [Abstract] [Full Text] [Related]
35. B lymphocyte lineage cells in newborn and very young NZB mice: evidence for regulatory disorders affecting B cell formation. Jyonouchi H, Kincade PW, Good RA, Gershwin ME. J Immunol; 1983 Nov 15; 131(5):2219-25. PubMed ID: 6605377 [Abstract] [Full Text] [Related]
36. Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice. Li P, Schwarz EM, O'Keefe RJ, Ma L, Looney RJ, Ritchlin CT, Boyce BF, Xing L. Arthritis Rheum; 2004 Jan 15; 50(1):265-76. PubMed ID: 14730625 [Abstract] [Full Text] [Related]
37. [Coculture of dendritic cell with cytokine-induced killer results in a significant increase in cytotoxic activity of CIK to tumor cells in vitro and in vivo]. Ge W, Li CH, Zhang W, Han Q, Deng WM, Chen L, You SG, Zhao CH. Zhonghua Xue Ye Xue Za Zhi; 2004 May 15; 25(5):277-80. PubMed ID: 15182535 [Abstract] [Full Text] [Related]
38. Stimulation of B-cell lymphopoiesis by interleukin-7 leads to aggravation of murine leishmaniasis. Gessner A, Will A, Vieth M, Schröppel K, Röllinghoff M. Immunology; 1995 Mar 15; 84(3):416-22. PubMed ID: 7751025 [Abstract] [Full Text] [Related]
39. Autogenous production of a hemopoietic growth factor, persisting-cell-stimulating factor, as a mechanism for transformation of bone marrow-derived cells. Schrader JW, Crapper RM. Proc Natl Acad Sci U S A; 1983 Nov 15; 80(22):6892-6. PubMed ID: 6417657 [Abstract] [Full Text] [Related]
40. Studies on the in vivo production of a lymphokine activity, interleukin 3 (IL-3) elaborated by lymphocytes and a myeloid leukaemic line in vitro and the fate of IL-3 dependent cell lines. Garland JM, Aldridge A, Wagstaffe J, Dexter TM. Br J Cancer; 1983 Aug 15; 48(2):247-59. PubMed ID: 6411109 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]